A case of hyperthyroidy developing in "pegylated-interferon" therapy

被引：2

作者：

Aslan, Mehmet

Nazligul, Yasar

Aksoy, Nurten

Yilmaz, Nevin

机构：

[1] Harran Univ, Dept Gastroenterol, Fac Med, TR-63200 Sanliurfa, Turkey

[2] Harran Univ, Dept Clin Chem, Fac Med, TR-63200 Sanliurfa, Turkey

来源：

DIGESTIVE DISEASES AND SCIENCES | 2007年 / 52卷 / 05期

关键词：

Pegylated interferon alpha-2b; Chronic hepatitis B; Hyperthyroidy;

D O I：

10.1007/s10620-006-9318-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：1194 / 1196

页数：3

共 19 条

[1]

ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578

[2]

DIANZANI F, 1993, GUT, V34, P74

[3]

Long-term outcome of interferon-α-induced autoimmune thyroid disorders in chronic hepatitis C [J].

Doi, F ;

Kakizaki, S ;

Takagi, H ;

Murakami, M ;

Sohara, N ;

Otsuka, T ;

Abe, T ;

Mori, M .

LIVER INTERNATIONAL, 2005, 25 (02) :242-246

[4]

DOLAR E, 2002, VIRAL DIS LIVER HEPA, P247

[5]

Dusheiko G., 1997, HEPATOLOGY S1, V26, p112S

[6]

FERNANDEZ DS, 2002, REV ESP ENFERM DIG, V94, P159

[7]

Pegylated interferon-α2b:: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data [J].

Glue, P ;

Fang, JWS ;

Rouzier-Panis, R ;

Raffanel, C ;

Sabo, R ;

Gupta, SK ;

Salfi, M ;

Jacobs, S .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (05) :556-567

[8]

Global control of hepatitis B virus infection [J].

Kao, JH ;

Chen, DS .

LANCET INFECTIOUS DISEASES, 2002, 2 (07) :395-403

[9]

Interferon-α induced thyroid dysfunction:: Three clinical presentations and a review of the literature [J].

Koh, LKH ;

Greenspan, FS ;

Yeo, PPB .

THYROID, 1997, 7 (06) :891-896

[10]

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update [J].

Liaw, YF ;

Leung, N ;

Guan, R ;

Lau, GKK ;

Merican, I ;

McCaughan, G ;

Gane, E ;

Kao, JH ;

Omata, M .

LIVER INTERNATIONAL, 2005, 25 (03) :472-489

← 1 2 →